Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.
Borkow
Gadi
G
R. Ben-Ari Institute of Clinical Immunology and AIDS Center, Kaplan Medical Center, Hebrew University Hadassah Medical School, Rehovot, Israel.
Bentwich
Zvi
Z
D016915:AIDS Vaccines / Q000276:immunology*; D000349:Africa; D000818:Animals; D003906:Developing Countries; D015195:Drug Design; D015658:HIV Infections / Q000150:complications / Q000276:immunology*; D006373:Helminthiasis / Q000276:immunology*; D006801:Humans; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D016915:AIDS Vaccines